发明授权
- 专利标题： Compounds which modulate the CB2 receptor
- 专利标题（中）： 调节CB2受体的化合物
-
申请号： US13022866申请日： 2011-02-08
-
公开(公告)号： US08829034B2公开(公告)日： 2014-09-09
- 发明人: Angela Berry , Pier Francesco Cirillo , Eugene Richard Hickey , Doris Riether , David Thomson , Renee M. Zindell , Nigel Blumire , Chandana Parke , Monika Ermann , James Edward Jenkins , Innocent Mushi , Christopher Francis Palmer , Malcolm Taylor
- 申请人： Angela Berry , Pier Francesco Cirillo , Eugene Richard Hickey , Doris Riether , David Thomson , Renee M. Zindell , Nigel Blumire , Chandana Parke , Monika Ermann , James Edward Jenkins , Innocent Mushi , Christopher Francis Palmer , Malcolm Taylor
- 申请人地址： DE Ingelheim am Rhein
- 专利权人： Boehringer Ingerlheim International GmbH
- 当前专利权人： Boehringer Ingerlheim International GmbH
- 当前专利权人地址： DE Ingelheim am Rhein
- 代理商 Michael P. Morris; Anthony P. Bottino
- 主分类号： C07D409/04
- IPC分类号： C07D409/04 ; C07D309/02 ; A61K31/351 ; A61K31/42 ; C07D261/12 ; C07D217/22 ; C07D277/82 ; C07D309/04 ; C07D277/46 ; C07C317/44 ; C07D213/75 ; C07D417/12 ; C07D407/12 ; C07D405/12 ; C07D413/12 ; C07D215/38 ; C07D403/12 ; C07D231/40
摘要：
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
公开/授权文献
- US20110130431A1 Compounds Which Modulate The CB2 Receptor 公开/授权日：2011-06-02
信息查询
